1. Naturally occurring heterocyclic anticancer compounds
   Shashi Kiran Misra et al, 2023, Physical Sciences Reviews CrossRef
2. Isobavachalcone’s Alleviation of Pyroptosis Contributes to Enhanced Apoptosis in Glioblastoma: Possible Involvement of NLRP3
   Yueshan Wu et al, 2022, Molecular Neurobiology CrossRef
3. Isobavachalcone attenuates myotube atrophy induced by TNF‐α through muscle atrophy F‐box signaling and the nuclear factor erythroid 2‐related factor 2 cascade
   Jinyoung Hur et al, 2019, Phytotherapy Research CrossRef
4. Oncopreventive and Oncotherapeutic Potential of Licorice Chalcone Compounds: Molecular Insights
   Yushu Wang et al, 2023, Mini-Reviews in Medicinal Chemistry CrossRef
5. Knockdown of ectodysplasin‑A receptor‑associated adaptor protein exerts a tumor‑suppressive effect in tongue squamous cell carcinoma cells
   Meng Li et al, 2020, Experimental and Therapeutic Medicine CrossRef
6. Sevoflurane Attenuates Proliferative and Migratory Activity of Lung Cancer Cells via Mediating the MicroRNA-100-3p/Sterol O-Acyltransferase 1 Axis
   Bicheng Fu et al, 2023, Chinese Journal of Physiology CrossRef
7. A comprehensive review of antitumor properties of Angelica species and their antitumor‐responsible constituents and the underlying molecular mechanisms involved in tumor inhibition
   Zufa Sabeel et al, 2023, Phytotherapy Research CrossRef
8. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway
   Peter Takac et al, 2018, Chemico-Biological Interactions CrossRef
9. Advances on resources, biosynthesis pathway, bioavailability, bioactivity, and application of corylifolinin
   Shengxiong Chen et al, 2024, Future Postharvest and Food CrossRef
10. Pharmacological review of isobavachalcone, a naturally occurring chalcone
    Miaojuan Wang et al, 2021, Pharmacological Research CrossRef
11. Chalcones: Synthetic Chemistry Follows Where Nature Leads
    Hiba A. Jasim et al, 2021, Biomolecules CrossRef
12. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer
    Amr Ahmed WalyEldeen et al, 2023, Chemico-Biological Interactions CrossRef
13. Design and Synthesis of Isobavachalcone Derivatives as Potential Dihydroorotate Dehydrogenase Inhibitors
    Wen Zhang et al, 2023, ChemistrySelect CrossRef
14. Isobavachalcone, a natural sirtuin 2 inhibitor, exhibits anti‐triple‐negative breast cancer efficacy in vitro and in vivo
    Ya‐li Ren et al, 2024, Phytotherapy Research CrossRef
15. Inhibitory Effects of Isobavachalcone on Tau Protein Aggregation, Tau Phosphorylation, and Oligomeric Tau-Induced Apoptosis
    Shifeng Xiao et al, 2021, ACS Chemical Neuroscience CrossRef
16. Molecular Mechanisms of Antiproliferative Effects of Natural Chalcones
    Radka Michalkova et al, 2021, Cancers CrossRef
17. Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents
    Jiahui Yang et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
18. Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives
    Lele Zhang et al, 2022, European Journal of Medicinal Chemistry CrossRef
19. Isobavachalcone: A comprehensive review of its plant sources, pharmacokinetics, toxicity, pharmacological activities and related molecular mechanisms
    Nan Xing et al, 2022, Phytotherapy Research CrossRef